ConforMIS yesterday announced the results from 6 clinical studies of its iTotal CR knee replacement at the 2015 Pan Pacific International Congress for Joint Reconstruction. One ongoing 295-patient study reported that patients treated with the iTotal CR knee replacement were 170% more likely to have excellent or good Knee Society Scores, according to the company. A […]
conformis
ConforMIS prices $135m IPO
ConforMIS yesterday priced its initial public offering at $15 per share, for total proceeds of $135 million. The 9-million-share IPO also includes a 1.35-million underwriters over-allotment option, Bedford, Mass.-based ConforMIS said. Earlier this month the company set the terms for its forthcoming initial public offering, saying it plans to float 9 million shares at $14 to $16 […]
ConforMIS sets terms for $135m IPO
ConforMIS today set the terms for its forthcoming initial public offering, saying it plans to float 9 million shares at $14 to $16 apiece. At the midpoint of the range, the IPO would fetch $135 million. Bedford, Mass.-based ConforMIS said last month that the IPO could bring in as much as $172.5 million. The company plans […]
ConforMIS files for $173m IPO
ConforMIS today unveiled plans for an initial public offering worth up to $172.5 million, saying it plans to file for FDA approval of its customized hip implant this year.
Bedford, Mass.-based ConforMIS said it plans to trade on the NASDAQ exchange under the CFMS symbol. The company originally filed confidentially March 20, according to the SEC.
Wright Medical, ConforMIS settle patent dispute
ConforMIS raises $168M Series E round
ConforMIS closed a Series E round worth $167.7 million, raised from a consortium of 88 unnamed investors, according to regulatory filings.
The Bedford, Mass.-based medical device company makes personalized knee implants based on scans detailing patients’ physiology, creating customized instruments and implants that are shipped in a sterile package surgeons can open on the operating table.
Reached by MassDevice.com today, CEO Philipp Lang declined to comment on the company’s latest funding round.
News makers and game changers at the MassDevice Big 100 East 2013
Nearly 300 of the industry’s best and brightest gathered for a night of big ideas, industry insights and few cocktails last night at MassDevice.com’s Big 100 East 2013 conference in Waltham, Mass.
ConforMIS lures Zimmer ops director to be its new operations SVP | Personnel Moves
ConforMIS lured Zimmer’s dental business operations director, Matthew Scott, away to be its new chief operating officer as it looks to scale up its customized knee implant business.
The Bedford, Mass.-based medical device company said Scott bring’s a decade’s worth of ops experience from his tenure at Zimmer. ConforMIS makes knee replacement implants and instrumentation that are custom-fit to patients’ morphology.
Mako Surgical sues Stanmore Implants over robotic surgery patents
Mako Surgical (NSDQ:MAKO) filed a pair of lawsuits against Stanmore Implants alleging patent infringement over robotic surgery technology, and filed a complaint with the U.S. International Trade Commission over the alleged violations.
ConforMIS sues Acacia Research over disingenuous access to confidential docs
Medical device maker ConforMIS filed a counter-suit against a patent holder and a patent management firm, claiming the pair used disingenuous means to acquire information in support of an infringement case against the company.
Knee replacement: Stanmore nabs FDA clearance for robotic guidance system
U.K.-based orthopedic device maker Stanmore Implants says it has received FDA clearance for its Sculptor Robotic Guidance Arm system for partial knee resurfacing procedures.
The system uses a robotic guidance arm to assist surgeons’ operation of cutting tools, and "limiting the removal of bone to a pre-defined safe area," according to a prepared release. It is part of a suite of devices and software systems the company produces for personalized orthopedic implants.